IL120862A0 - Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders acute liver disorders and the complications associated therewith - Google Patents

Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders acute liver disorders and the complications associated therewith

Info

Publication number
IL120862A0
IL120862A0 IL12086297A IL12086297A IL120862A0 IL 120862 A0 IL120862 A0 IL 120862A0 IL 12086297 A IL12086297 A IL 12086297A IL 12086297 A IL12086297 A IL 12086297A IL 120862 A0 IL120862 A0 IL 120862A0
Authority
IL
Israel
Prior art keywords
liver disorders
prevention
treatment
associated therewith
complications associated
Prior art date
Application number
IL12086297A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996120509 external-priority patent/DE19620509A1/de
Priority claimed from DE19632042A external-priority patent/DE19632042A1/de
Priority claimed from DE19639303A external-priority patent/DE19639303A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL120862A0 publication Critical patent/IL120862A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL12086297A 1996-05-22 1997-05-20 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders acute liver disorders and the complications associated therewith IL120862A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE1996120509 DE19620509A1 (de) 1996-05-22 1996-05-22 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19632042A DE19632042A1 (de) 1996-08-08 1996-08-08 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19639303A DE19639303A1 (de) 1996-09-25 1996-09-25 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
US08/858,550 US5786365A (en) 1996-05-22 1997-05-19 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith

Publications (1)

Publication Number Publication Date
IL120862A0 true IL120862A0 (en) 1997-09-30

Family

ID=27438369

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12086297A IL120862A0 (en) 1996-05-22 1997-05-20 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders acute liver disorders and the complications associated therewith

Country Status (23)

Country Link
US (1) US5786365A (cs)
EP (2) EP0808627A2 (cs)
JP (1) JP4034849B2 (cs)
CN (1) CN1176102A (cs)
AT (1) ATE189389T1 (cs)
AU (1) AU2351197A (cs)
BR (1) BR9703367A (cs)
CA (1) CA2205780A1 (cs)
CZ (1) CZ154697A3 (cs)
DE (1) DE59701078D1 (cs)
DK (1) DK0808628T3 (cs)
ES (1) ES2144291T3 (cs)
GR (1) GR3033048T3 (cs)
HR (1) HRP970278A2 (cs)
HU (1) HUP9700913A1 (cs)
ID (1) ID18447A (cs)
IL (1) IL120862A0 (cs)
NO (1) NO972311L (cs)
PL (1) PL320134A1 (cs)
PT (1) PT808628E (cs)
SI (1) SI0808628T1 (cs)
SK (1) SK63097A3 (cs)
TR (1) TR199700392A2 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935581A (en) * 1996-07-24 1999-08-10 Kapadia; Govind J. Inhibitory effects of synthetic and natural colorants on carcinogenesis
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19712960A1 (de) * 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
DE69931140T2 (de) 1998-11-10 2007-02-01 Temple University Of The Commonwealth System Of Higher Education Hemmung der angiogenese durch peptidanaloge der kininogen domäne 5mit hohem molekulargewicht
US6767889B1 (en) 1998-11-10 2004-07-27 Temple University Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
JP2002529474A (ja) * 1998-11-10 2002-09-10 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 高分子量キニノゲン及びそのペプチド類似体による血管形成の抑制
US6869931B1 (en) 1998-12-16 2005-03-22 Temple University - Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
US6994852B1 (en) 1999-11-12 2006-02-07 Temple University-Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5
US6445588B1 (en) 2001-01-02 2002-09-03 Motorola, Inc. Apparatus and method for securing a printed circuit board to a base plate
RU2006124843A (ru) 2003-12-12 2008-01-20 Уайт (Us) Хинолины, пригодные для лечения сердечно-сосудистого заболевания
CA2603589A1 (en) * 2005-04-01 2006-10-05 Methylgene Inc. Inhibitors of histone deacetylase
MX2012014948A (es) * 2010-06-29 2013-05-17 Jennifer Digrazia Sistema y metodo para proteccion de apositos y herbicidas.
US12427067B2 (en) 2010-06-29 2025-09-30 Jennifer DiGrazia Wound and bandage protection system and method
US10517765B2 (en) 2010-06-29 2019-12-31 Jennifer DiGrazia Wound and bandage protection system and method
RU2514345C1 (ru) * 2012-10-09 2014-04-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования степени риска геморрагических осложнений при миниинвазивных хирургических вмешательствах на печени

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212182A (en) * 1990-10-03 1993-05-18 American Home Products Corpooration Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
AU686115B2 (en) * 1992-11-02 1998-02-05 Fujisawa Pharmaceutical Co., Ltd. Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
JP3049648B2 (ja) * 1993-12-13 2000-06-05 日立金属株式会社 加圧成形方法および加圧成形機
WO1996004251A1 (en) * 1994-08-03 1996-02-15 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic compound

Also Published As

Publication number Publication date
SI0808628T1 (en) 2000-04-30
CA2205780A1 (en) 1997-11-22
EP0808627A2 (de) 1997-11-26
HUP9700913A1 (hu) 1999-09-28
AU2351197A (en) 1997-11-27
GR3033048T3 (en) 2000-08-31
CZ154697A3 (en) 1997-12-17
ATE189389T1 (de) 2000-02-15
PT808628E (pt) 2000-05-31
NO972311D0 (no) 1997-05-21
JPH1045624A (ja) 1998-02-17
JP4034849B2 (ja) 2008-01-16
PL320134A1 (en) 1997-11-24
TR199700392A2 (xx) 1997-12-21
CN1176102A (zh) 1998-03-18
DE59701078D1 (de) 2000-03-09
SK63097A3 (en) 1997-12-10
NO972311L (no) 1997-11-24
ID18447A (id) 1998-04-09
EP0808628A3 (de) 1998-01-14
EP0808628B1 (de) 2000-02-02
ES2144291T3 (es) 2000-06-01
BR9703367A (pt) 1998-09-15
MX9703725A (es) 1997-11-29
HU9700913D0 (en) 1997-07-28
US5786365A (en) 1998-07-28
EP0808628A2 (de) 1997-11-26
DK0808628T3 (da) 2000-06-26
HRP970278A2 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
IL120862A0 (en) Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders acute liver disorders and the complications associated therewith
LU91417I2 (fr) "Maraviroc, optionnellement sous forme d'un sel pharmaceutiquement acceptable CELSENTRI"
EP0454501A3 (en) Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides
PT863136E (pt) Derivados de azetidina e de pirrolidina
FI935360A0 (fi) Guanidinalkyl-1,1-bifosfonsyraderivat, foerfarande foer deras framstaellning samt deras anvaendning
PL350775A1 (en) Pharmaceutical compounds
NO931401L (no) Steroidderivater for behandling av prostatahypertrofi, samt fremstilling og anvendelse derav
AU2215588A (en) Substituted cycloalkanols
TW200504085A (en) Derivatives of [2-(8,9-dioxo-2, 6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of use thereof
ATE284692T1 (de) Verwendung von nicht-peptidischen bradykinin- antagonisten zur herstellung von arzneimitteln zur behandlung und prävention der alzheimerischen krankheit
CA2321188A1 (en) Derivatives of azetidine and pyrrolidine
ATE324362T1 (de) Neue vinylbenzolderivate
DK0838223T3 (da) Hjerneødeminhibitor
EP1152004A4 (en) PHOSPHONIC ACID DERIVATIVES HAVING CARBOXYPEPTIDASE B INHIBITOR ACTIVITY
ATE97810T1 (de) Injizierbare cephalosporinpraeparate und ihre anwendung.
ES2188260T3 (es) 3-tetrahidropiridin-4-il-indoles para el tratamiento de trastornos pscoticos.
NO975903D0 (no) N-benzylpiperazin-forbindelser, fremgangsmåte ved fremstilling derav, samt farmasöytiske blandinger
GB8706662D0 (en) Anti-arrhythmia agents
PT955286E (pt) Derivados do di-hidro ou tetra-hidronaftaleno tendo uma actividade (ani-)estrogenica
ZA987963B (en) Disubstituted trans-3,4,4a,5,6,10b-haxahydro-2H-naphth(1,2-b)-1,4-oxazines a process for their preparation and pharmaceutical compositions containing them
ATE250027T1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
PL329885A1 (en) Derivatives of polyhydroxyphenol and agents containing them for use in prophylactics and treatment of bone and cartilage diseases
CO4970784A1 (es) Antagonistas del receptor de fibrinogen